Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
Reumatismo
  • Search
  • Contacts
  • News
  • Register
  • Login
  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Early Access
  • Archives
    • Overview
  • Search
  • Contacts
  • News
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

23 results for “biologics.”

  • Biologics targeted at TNF: design, production and challenges

    B. Gatto

    Pages 94-103

    DOI https://doi.org/10.4081/reumatismo.2006.94

    • 2,142 abstract views
    • 2,782 PDF
  • Update on treatment of polymyalgia rheumatica

    D. Camellino, C. Dejaco

    27-03-2018 Pages 59-66

    DOI https://doi.org/10.4081/reumatismo.2018.1062

    • 6,558 abstract views
    • 3,680 PDF
  • Psoriatic arthritis: treatment strategies using biologic agents

    S. D'Angelo, C. Palazzi, I. Olivieri

    05-06-2012 Pages 113-121

    DOI https://doi.org/10.4081/reumatismo.2012.113

    • 1,643 abstract views
    • 1,309 PDF
  • The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

    Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

    23-07-2025

    DOI https://doi.org/10.4081/reumatismo.2025.1830

    • 2,833 abstract views
    • 566 PDF
  • PO:15:209 | Attainment of remission or lupus low disease activity state in single center Lupus Clinic

    Paola Tedoldi1|2, Silvia Ebe Lucia Della Pina1|2, Claudia Barison1|2, Chiara Orlandi1|2, Cecilia Nalli1, Micaela Fredi2, Ilaria Cavazzana1|2, Franco Franceschini1|2 | 1Rheumatology and Clinical Immunology Unit- ERN ReCONNET, ASST Spedali Civili of Brescia Brescia, Italy; 2Department of Clinical and Experimental Sciences, University of Brescia Brescia, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2325

    • 181 abstract views
  • PO:17:253 | Unveiling the gap: a multicenter study on factors driving patient-physician discrepancies in assessing disease activity in systemic lupus erythematosus

    Giorgia Ingrid Gozzoli1, Micaela Fredi1, Federica Bonaso1, Silvia Ebe Lucia Della Pina1, Claudia Barison1, Irene Lorenzini4, Raffaele Pericotti4, Anna Mattiuzzo4, Marcelo Neto2, Sofia Azevedo3, Cláudia Oliveira3, Cesare Tomasi4, Luís Sousa Inês2, Franco Franceschini1. | 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy; 2Rheumatology Department, Centro Hospitalar Universitário de Coimbra - ULS Coimbra, Coimbra, Portugal; 3Rheumatology  Department, ULS Aveiro, Aveiro, Portugal; 4Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2046

    • 329 abstract views
  • Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

    M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

    31-03-2015 Pages 285-303

    DOI https://doi.org/10.4081/reumatismo.2014.799

    • 2,966 abstract views
    • 2,495 PDF
  • PO:36:252 | Long-Term Outcomes of Patients with Takayasu Arteritis in the Era of Biological Agents: a Multicenter International Study

    Alessandro Tomelleri1, Durga Prasanna Misra2, Fatma Alibaz-Oner3, Chiara Marvisi4, Chiara Calabrese1, Upendra Rathore2, Aysegul Avcu3, Adele Del Giudice4, Elisabetta Olivi4, Caterina Ricordi4, Corrado Campochiaro1, Elena Baldissera1, Marco Matucci-Cerinic1, Haner Direskeneli3, Carlo Salvarani4, Lorenzo Dagna1 | 1IRCCS Ospedale San Raffaele, Unità di Immunologia, Reumatologia, Allergologia e Malattie Rare Milano, Italy; 2Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS, Clinical Immunology and Rheumatology Lucknow Country, India; 3Marmara University, School of Medicine, Department of Internal Medicine, Division of Rheumatology Istanbul, Turkey; 4Azienda USL-IRCCS di Reggio Emilia, Unità di Reumatologia Reggio Emilia, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2389

    • 175 abstract views
  • PO:11:162 | DRESS syndrome: a case treated with mepolizumab

    Alessandro Belotti Masserini1, Stefania Bertocchi1, Eleonora Bruschi1, Silvia Breda1, Valeria Rossi1, Elide Lupi1, Tania Ubiali1, Fabrizio Angeli1, Massimiliano Limonta1 | 1ASST Papa Giovanni XXIII, Bergamo, Italy

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2152

    • 432 abstract views
  • PO:08:124 | An exploratory analysis of risk factors for methotrexate-associated osteopathy: a retrospective study

    Federico Aldegheri1, Francesca Ruzzon1, Matteo Appoloni1, Maurizio Rossini1, Giovanni Adami1, Davide Gatti1, Ombretta Viapiana1, Angelo Fassio1 | 1Università di Verona, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2308

    • 183 abstract views
  • S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study

    Miriam Guerini1, Pavel Novikov2, Roberto Padoan3, Georgina Espigol Frigolé4, Jan Willem Cohen Tervaert5, Vincent Grobost6, Laurent Guilleminault7, Jan Walter Schroeder8, Bernhard Hellmich9, Joana Martins Martinho10, Camillo Ribi11, Matthieu Groh12, Benjamin Terrier13. | 1IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; 2Sechenov University, Moscow, Russia; 3University of Padova, Padova, Italy; 4Hospital Clinic, University of Barcelona, Barcelona, Spain; 5University of Alberta, Edmonton, Canada; 6CHU Estaing Clermont-Ferrand France; 7Toulouse University Toulouse France; 8ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 9Medius Kliniken Kirchheim-Teck Germany; 10ULS Santa Maria, Lisbon, Portugal; 11Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 12Hopital Foch, Suresnes, France; 13Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2101

    • 395 abstract views
  • Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

    L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

    Pages 182-186

    DOI https://doi.org/10.4081/reumatismo.2009.182

    • 1,211 abstract views
    • 887 PDF
  • PO:30:157 | Radiographic assessment of measurable osteoarticular damage in juvenile idiopathic arthritis (JIA) patients transitioning to adult care

    Serena Pastore4, Marta Klanmjsceck3, Andrea Guiotto1, Laura De Nardi5|6, Alessia Pin4, Lorenzo Cereser1|2, Andrea Taddio3|4, Luisa Occhipinti1, Luca Quartuccio1|2, Alberto Tommasini3|4, Alen Zabotti2 | 1Università degli Studi di Udine Udine, Italy; 2Ospedale Santa Maria della Misericordia Udine, Italy; 3Università degli Studi di Trieste Trieste, Italy; 4IRCCS Materno Infantile Burlo Garofolo Trieste, Italy; 5Università Tor Vergata Roma, Italy; 6Ospedale Pediatrico Bambino Gesù Roma, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2365

    • 235 abstract views
  • MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

    P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

    Pages 132-139

    DOI https://doi.org/10.4081/reumatismo.2009.132

    • 2,276 abstract views
    • 1,294 PDF
  • PO:04:061 | Higher prevalence of baseline comorbidities in patients developing difficult to treat psoriatic arthritis

    Mario Ferraioli1, Michelina Turri1, Eneida Çela1, Mauro Fatica1, Paola Conigliaro1, Elisabetta Greco1, Alberto Bergamini1, Maria Sole Chimenti1. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome, Tor Vergata, Rome, Italy.

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2011

    • 288 abstract views
  • PO:21:026 | Identifying patient profiles to personalize care and improve quality of life in italian EGPA patients

    Francesca Torracca1, Roberto Padoan2, Giacomo Emmi3|4, Lara Bernardi5, Maria Rosaria Mollo5, Omar Shalby5, Fabio Tedone6, Davide Cafiero6, Eugenia Durante1 | 1APACS APS ETS - Associazione Pazienti Sindrome di Churg Strauss EGPA Arosio, Italy; 2Rheumatology Unit, Department of Medicine DIMED, University of Padua, Italy; 3Department of Medical, Surgical and Health Sciences, University of Trieste, Italy; 4Clinical Medicine Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; 5GlaxoSmithKline Medical Department Verona, Italy; 6Helaglobe SRL Firenze, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2344

    • 134 abstract views
  • Leishmaniasis in rheumatoid arthritis

    C. Pizzorni, M.E. Secchi, M. Cutolo

    Pages 235-239

    DOI https://doi.org/10.4081/reumatismo.2007.235

    • 1,806 abstract views
    • 1,174 PDF
  • The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease

    Ennio Lubrano, Alessandro Armuzzi, Silvia Scriffignano, Carla Felice, Fabio Massimo Perrotta, Vincenzo Venerito, Sergio Del Vescovo, Roberta Ramonda, Giulia Cassone, Fabiola Atzeni, Roberto Caporali, Fabrizio Conti, Elisa Gremese, Florenzo Iannone, Marco Sebastiani, Ennio Giulio Favalli

    11-11-2024

    DOI https://doi.org/10.4081/reumatismo.2024.1688

    • 2,686 abstract views
    • 1,330 PDF
  • PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience

    Federica Davanzo1, Caterina Menghi2, Andrea Silvio Giordani2, Anna Baritussio2, Federico Scognamiglio2, Cristina Vicenzetto2, Luca Iorio1, Renzo Marcolongo2, Cristina Basso3, Andrea Doria1, Roberto Padoan1, Alida Linda Patr Caforio2 | 1Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; 2Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; 3Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2383

    • 180 abstract views
  • PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort

    Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2043

    • 309 abstract views
  • PO:35:224 | Capturing What BVAS Misses: Patient-Reported Outcomes Reflect Disease Activity and Burden in EGPA

    Marta Codirenzi1, Federica Davanzo1, Luca Iorio1, Eleonora Fiorin1, Roberta Prevedello1, Roberto Padoan1, Andrea Doria1 | 1Unità di reumatologia, dipartimento di medicina DIMED,Università degli studi di Padova, Italy

    Società Italiana di Reumatologia

    18-03-2026

    DOI https://doi.org/10.4081/reumatismo.2025.2384

    • 121 abstract views
  • Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

    C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

    Pages 224-235

    DOI https://doi.org/10.4081/reumatismo.2003.224

    • 1,419 abstract views
    • 2,911 PDF
  • PO:01:006 | Increased risk of cancer recurrence or mortality associated with DMARDs?

    Laura Scagnellato1, Giacomo Cozzi1, Mariagrazia Lorenzin1, Mariangela Salvato1, Alessandro Giollo1, Bernd Raffeiner1, Antonia Calligaro1, Teresa Del Ross1, Sara Bindoli1, Margherita Zen1, Paolo Sfriso1, Andrea Doria1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina dei Sistemi DIMED, Ospedale Università di Padova, Padova, Italy.

    Società Italiana di Reumatologia

    25-11-2025

    DOI https://doi.org/10.4081/reumatismo.2025.2003

    • 342 abstract views
1 - 23 of 23 items

Submit your article

Read the guidelines for authors before you start your submission.

Make a Submission

authors

FOR AUTHORS
  • ARTICLE PROCESSING CHARGE
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review
  • Thanks to Reviewers

Categories

    • Abstract Book
    • Oral Communications - Day 1
    • Posters - Day 1
    • Oral Communications - Day 2
    • Posters - Day 2
    • Oral Communications - Day 3

indexing

INDEXING
  • PubMed
  • Scopus
  • Web of Science
  • Google Scholar
  • OpenAlex
  • Scilit
  • DOAJ
  • Società Italiana di Reumatologia
  • Analytics

social

Follow Reumatismo on

Keywords

Reumatismo

is the Official Journal of the Italian Society of Rheumatology (SIR). Founded in 1949. Published online by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN 0048-7449
eISSN 2240-2683

The journal

  • About the Journal
  • Editorial board
  • Archives
  • Announcements
  • Contact

For authors

  • Submissions
  • Guidelines for authors
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.